Institutional investors adjust stakes in Synopsys and ARS Pharmaceuticals

Institutional investors have made significant adjustments to their holdings in Synopsys, Inc. and ARS Pharmaceuticals, Inc., according to recent SEC filings.

Tensor Edge Capital LLC increased its stake in the semiconductor company Synopsys, Inc. by 127.7% during the second quarter, bringing its total ownership to 210,000 shares valued at approximately $93,675,000. Other major institutions, including Vanguard Group Inc., State Street Corp, Morgan Stanley, and Geode Capital Management LLC, also reported increased positions in the company during recent quarters.

In the pharmaceutical sector, Hennion & Walsh Asset Management Inc. established a new position in ARS Pharmaceuticals, Inc. during the second quarter, acquiring 175,614 shares valued at roughly $1,407,000. Other firms, such as Mirae Asset Global Investments Co. Ltd. and BNP Paribas Financial Markets, also reported growth in their respective holdings of the company.